KATRD
LOGIN
- KATRD 2021 International Conference
-
November 7(Thu)-8(Fri), 2020 Lotte Hotel World, Seoul, Kore
Program in Detail
|
Oral Presentation 11 Asthma |
10:10-10:30 |
||
|---|---|---|---|
| Chair | |||
| 13:30-13:40 | OP 11-1 |
Dupilumab Efficacy in Patients with GINA-Defined Type 2 Asthma: Traverse
|
|
| 13:40-13:50 | OP 11-2 |
Prevalence of Asthma-COPD Overlap in COPD and Severe Asthma Cohorts
|
|
| 13:50-14:00 | OP 11-3 |
Comparative Efficacy and Safety Between Budesonide-formoterol and Fluticasone-salmeterol Combination Inhalers for Asthma Management: Retrospective Analysis from the Common Data Model
|
|
| 14:00-14:10 | OP 11-4 |
Clinical Characteristics of Korean Severe Asthma Patients
|
|
| 14:10-14:20 | OP 11-5 |
Rootletin is a Marker for Asthma Exacerbation in Patients with Asthma: Implication for Diesel Exhaust Particles
|
|
| 14:20-14:30 | OP 11-6 |
The Prevalence of and Factors Associated with Influenza Vaccination in Patients with Asthma in Korea
|
|
| 14:30-14:40 | OP 11-7 |
Cardiovascular and Cerebrovascular Mortality in Asthma Patients with Preceding Exacerbation
|
|
| 14:40-14:50 | OP 11-8 |
Pharmacovigilance Studies of Oral Salbutamol in Chronic Asthmatic Patients in Different Clinical Setups of Hyderabad, Sindh, Pakistan
|
|